prevension of SSI by very low-dose naloxone

prevension of SSI by very low-dose naloxone - naloxone and SSI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023295

Enrollment

300

Registered

2016-09-01

Start date

2016-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal surgery

Interventions

Administration of Saline as control from the start of anesthesi to the end of surgery Administration of very low-dose naloxone(0.25ug/kg/hr)under remifentanil based anesthesia from strat of anesthes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Colorectal cancer surgety in respective institusion

Exclusion criteria

Exclusion criteria: Reoperation patients with ireus tube emergency operation patients who declined

Design outcomes

Primary

Measure	Time frame
Incidence of postoperative SSI	—

Countries

Japan

Contacts

Public ContactYoshiharu Kameda

Nippon Medical School Musashikosugi Hospital syomuka

kameda@nms.ac.jp044-733-5181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026